EG25097A - Piprazinyl and diazapanyl benzamides and benzthioamides. - Google Patents
Piprazinyl and diazapanyl benzamides and benzthioamides.Info
- Publication number
- EG25097A EG25097A EGNA2005000151A EG25097A EG 25097 A EG25097 A EG 25097A EG NA2005000151 A EGNA2005000151 A EG NA2005000151A EG 25097 A EG25097 A EG 25097A
- Authority
- EG
- Egypt
- Prior art keywords
- benzthioamides
- piprazinyl
- diazapanyl
- benzamides
- diazapanyl benzamides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0463—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0465—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K51/047—Benzodiazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Otolaryngology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42049502P | 2002-10-23 | 2002-10-23 | |
PCT/US2003/033343 WO2004037801A1 (en) | 2002-10-23 | 2003-10-21 | Piperazinyl and diazapanyl benzamides and benzthioamides |
Publications (1)
Publication Number | Publication Date |
---|---|
EG25097A true EG25097A (en) | 2011-08-17 |
Family
ID=32176579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EGNA2005000151 EG25097A (en) | 2002-10-23 | 2005-04-20 | Piprazinyl and diazapanyl benzamides and benzthioamides. |
Country Status (33)
Country | Link |
---|---|
US (2) | US7414047B2 (el) |
EP (1) | EP1558595B1 (el) |
JP (1) | JP4596918B2 (el) |
KR (1) | KR101067732B1 (el) |
CN (1) | CN100558718C (el) |
AR (1) | AR041697A1 (el) |
AT (1) | ATE449766T1 (el) |
AU (1) | AU2003301552B2 (el) |
BR (1) | BRPI0315644B8 (el) |
CA (1) | CA2504269C (el) |
CR (1) | CR7807A (el) |
CY (1) | CY1109924T1 (el) |
DE (1) | DE60330269D1 (el) |
DK (1) | DK1558595T3 (el) |
EA (1) | EA009860B1 (el) |
EG (1) | EG25097A (el) |
ES (1) | ES2335584T3 (el) |
HK (1) | HK1086827A1 (el) |
HR (1) | HRP20050352B1 (el) |
IL (1) | IL168207A (el) |
ME (1) | ME00334B (el) |
MX (2) | MX339074B (el) |
MY (1) | MY140886A (el) |
NO (1) | NO330741B1 (el) |
NZ (2) | NZ576432A (el) |
PL (1) | PL215454B1 (el) |
PT (1) | PT1558595E (el) |
RS (1) | RS51681B (el) |
SI (1) | SI1558595T1 (el) |
TW (1) | TWI352594B (el) |
UA (1) | UA80573C2 (el) |
WO (1) | WO2004037801A1 (el) |
ZA (1) | ZA200504067B (el) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004037801A1 (en) | 2002-10-23 | 2004-05-06 | Janssen Pharmaceutica, N.V. | Piperazinyl and diazapanyl benzamides and benzthioamides |
GB0324159D0 (en) | 2003-10-15 | 2003-11-19 | Glaxo Group Ltd | Novel compounds |
JP2007531755A (ja) | 2004-03-31 | 2007-11-08 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 非イミダゾール系複素環式化合物 |
AU2005230902A1 (en) * | 2004-03-31 | 2005-10-20 | Janssen Pharmaceutica, N.V. | Non-imidazole heterocyclic compounds as histamine H3-receptor ligands |
ME01181B (me) * | 2005-09-16 | 2013-03-20 | Janssen Pharmaceutica Nv | Ciklopropil amini kao modulatori histaminskog h3 receptora |
CA2869539C (en) * | 2005-10-31 | 2017-06-27 | Mayra B. Reyes | Novel processes for the preparation of cyclopropyl-amide derivatives |
US7795426B2 (en) | 2005-10-31 | 2010-09-14 | Janssen Pharmaceutica Nv | Processes for the preparation of cyclopropyl-amide derivatives |
EP2404911A1 (en) * | 2005-10-31 | 2012-01-11 | Janssen Pharmaceutica NV | Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives |
ES2381205T3 (es) * | 2005-11-10 | 2012-05-24 | Msd K.K. | Derivado espiro aza-sustituido |
MY146506A (en) * | 2006-05-30 | 2012-08-15 | Janssen Pharmaceutica Nv | Substituted pyridyl amide compounds as modulators of the histamine h3 receptor |
US9108948B2 (en) | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
MX2008016343A (es) | 2006-06-23 | 2009-01-19 | Abbott Lab | Derivados ciclopropil amina como moduladores del receptro de histamina h3. |
EP2038269A1 (en) * | 2006-06-29 | 2009-03-25 | Janssen Pharmaceutica N.V. | Substituted benzamide modulators of the histamine h3 receptor |
CA2672661C (en) * | 2006-12-14 | 2015-04-28 | Janssen Pharmaceutica N.V. | Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
ES2384414T3 (es) * | 2007-09-06 | 2012-07-04 | Glaxo Group Limited | Derivado de piperazina que tiene afinidad por el receptor H3 de histamina |
AR068509A1 (es) * | 2007-09-19 | 2009-11-18 | Jerini Ag | Antagosnistas del receptor de bradiquinina b1 |
KR101546712B1 (ko) | 2007-11-20 | 2015-08-24 | 얀센 파마슈티카 엔.브이. | 히스타민 h3 수용체의 조절제로서 사이클로알킬옥시- 및 헤테로사이클로알킬옥시피리딘 화합물 |
US20100130477A1 (en) * | 2008-11-25 | 2010-05-27 | Astrazeneca Ab | Spirocyclobutyl Piperidine Derivatives |
EP3492451B1 (en) * | 2009-03-18 | 2021-11-03 | Janssen Pharmaceutica NV | Process for the preparation of histamine h3 receptor modulators |
US9186353B2 (en) | 2009-04-27 | 2015-11-17 | Abbvie Inc. | Treatment of osteoarthritis pain |
WO2012037258A1 (en) | 2010-09-16 | 2012-03-22 | Abbott Laboratories | Processes for preparing 1,2-substituted cyclopropyl derivatives |
RU2700595C1 (ru) * | 2019-07-30 | 2019-09-18 | Общество с ограниченной ответственностью "Кью Эм Фарма" | Производное 3,6,9-триазатрициклотетрадекана и его применение для лечения депрессии |
WO2022113008A1 (en) | 2020-11-27 | 2022-06-02 | Richter Gedeon Nyrt. | Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3714179A (en) | 1970-09-08 | 1973-01-30 | Searle & Co | 1-alkyl-2-furfurylthioimidazoles and congeners |
US3886160A (en) | 1972-09-28 | 1975-05-27 | Searle & Co | 2-(2-Methyl-5-nitro-1-imidazolyl) ethyl-2-thiopseudoureas |
EP0186817B1 (en) * | 1984-12-10 | 1989-08-02 | Nissan Chemical Industries Ltd. | 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it |
JP2813747B2 (ja) | 1989-05-22 | 1998-10-22 | 富士写真フイルム株式会社 | 画像形成法 |
US5030644A (en) | 1989-07-31 | 1991-07-09 | Merck & Co., Inc. | Imidazole compounds and their use as transglutaminase inhibitors |
US5492891A (en) | 1991-09-05 | 1996-02-20 | Novo Nordisk A/S | Method for treatment of patients with chronic liver disease |
US5569659A (en) | 1991-09-11 | 1996-10-29 | Mcneilab, Inc. | 4-arylpiperazines and 4-arylpiperidines |
US5352707A (en) * | 1992-03-26 | 1994-10-04 | Harbor Branch Oceanographic Institution, Inc. | Method for treating airway congestion |
US5217986A (en) | 1992-03-26 | 1993-06-08 | Harbor Branch Oceanographic Institution, Inc. | Anti-allergy agent |
US5681954A (en) | 1993-05-14 | 1997-10-28 | Daiichi Pharmaceutical Co., Ltd. | Piperazine derivatives |
RU2124511C1 (ru) | 1993-05-14 | 1999-01-10 | Фармасьютикал Ко., Лтд | Производные пиперазина |
US5464788A (en) | 1994-03-24 | 1995-11-07 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
EP0794779A4 (en) | 1994-12-22 | 1998-04-29 | Smithkline Beecham Corp | FIBRINOGENIC RECEPTOR ANTAGONISTS |
IL117149A0 (en) | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
US5889006A (en) | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
JPH09294056A (ja) * | 1996-04-25 | 1997-11-11 | Mitsubishi Electric Corp | 半導体集積回路 |
JPH1059954A (ja) | 1996-08-14 | 1998-03-03 | Takeda Chem Ind Ltd | 環状アミン誘導体およびそれを含んでなる医薬 |
US5869479A (en) | 1997-08-14 | 1999-02-09 | Schering Corporation | Treatment of upper airway allergic responses |
CA2306465A1 (en) | 1997-11-07 | 1999-05-20 | Daiichi Pharmaceutical Co. Ltd. | Piperazine-cyclodextrin complexes |
GB9803536D0 (en) | 1998-02-19 | 1998-04-15 | Black James Foundation | Histamine H,receptor ligands |
EP0978512A1 (en) * | 1998-07-29 | 2000-02-09 | Societe Civile Bioprojet | Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications |
ATE354568T1 (de) | 2000-08-08 | 2007-03-15 | Ortho Mcneil Pharm Inc | Nicht-imidazol aryloxypiperidine als h3 rezeptor liganden |
AU2001284733B2 (en) | 2000-08-08 | 2006-11-02 | Ortho-Mcneil Pharmaceutical, Inc. | Non-imidazole aryloxyalkylamines as H3 receptor ligands |
WO2002024695A2 (en) | 2000-09-22 | 2002-03-28 | Ortho Mcneil Pharmaceutical, Inc. | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
JP2004532834A (ja) | 2001-03-23 | 2004-10-28 | イーライ・リリー・アンド・カンパニー | ヒスタミンh3受容体アンタゴニストである非イミダゾール系アリールアルキルアミン化合物、その製造および治療的使用 |
AU2002344951A1 (en) | 2001-07-02 | 2003-01-21 | Boehringer Ingelheim International Gmbh | Substituted piperazine and diazepanes as histamine h3 receptor agonists |
WO2003024928A2 (en) | 2001-09-14 | 2003-03-27 | Novo Nordisk A/S | Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
DE60234616D1 (de) | 2001-09-14 | 2010-01-14 | High Point Pharmaceuticals Llc | Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren |
JP4563675B2 (ja) | 2001-10-12 | 2010-10-13 | ハイ・ポイント・ファーマスーティカルズ、エルエルシー | 置換ピペリジン類、およびヒスタミンh3受容体関連疾患の治療のためのその使用 |
PT1451167E (pt) | 2001-12-10 | 2006-07-31 | Ortho Mcneil Pharm Inc | Fenilalcinos |
WO2003055866A1 (en) * | 2001-12-21 | 2003-07-10 | Bayer Pharmaceuticals Corporation | Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
DE10201240A1 (de) * | 2002-01-15 | 2003-07-24 | Bayer Ag | Substituierte Alkyluracile und ihre Verwendung |
AU2003203143B2 (en) | 2002-02-01 | 2009-05-14 | High Point Pharmaceuticals, Llc | Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
WO2004037801A1 (en) | 2002-10-23 | 2004-05-06 | Janssen Pharmaceutica, N.V. | Piperazinyl and diazapanyl benzamides and benzthioamides |
WO2005035534A1 (ja) | 2003-10-08 | 2005-04-21 | Ono Pharmaceutical Co., Ltd. | 複素ビシクロ環および複素トリシクロ環化合物およびその医薬 |
GB0324159D0 (en) | 2003-10-15 | 2003-11-19 | Glaxo Group Ltd | Novel compounds |
-
2003
- 2003-10-21 WO PCT/US2003/033343 patent/WO2004037801A1/en active Application Filing
- 2003-10-21 MX MX2009006222A patent/MX339074B/es unknown
- 2003-10-21 JP JP2004546967A patent/JP4596918B2/ja not_active Expired - Fee Related
- 2003-10-21 CN CNB2003801070529A patent/CN100558718C/zh not_active Expired - Fee Related
- 2003-10-21 KR KR1020057006864A patent/KR101067732B1/ko active IP Right Grant
- 2003-10-21 RS YU20050317A patent/RS51681B/sr unknown
- 2003-10-21 NZ NZ576432A patent/NZ576432A/en not_active IP Right Cessation
- 2003-10-21 DE DE60330269T patent/DE60330269D1/de not_active Expired - Lifetime
- 2003-10-21 DK DK03809596.4T patent/DK1558595T3/da active
- 2003-10-21 ES ES03809596T patent/ES2335584T3/es not_active Expired - Lifetime
- 2003-10-21 CA CA2504269A patent/CA2504269C/en not_active Expired - Lifetime
- 2003-10-21 EP EP03809596A patent/EP1558595B1/en not_active Expired - Lifetime
- 2003-10-21 ME MEP-2008-495A patent/ME00334B/me unknown
- 2003-10-21 EA EA200500528A patent/EA009860B1/ru unknown
- 2003-10-21 NZ NZ539595A patent/NZ539595A/en not_active IP Right Cessation
- 2003-10-21 UA UAA200504801A patent/UA80573C2/uk unknown
- 2003-10-21 MX MXPA05004384A patent/MXPA05004384A/es active IP Right Grant
- 2003-10-21 US US10/690,115 patent/US7414047B2/en active Active
- 2003-10-21 AT AT03809596T patent/ATE449766T1/de active
- 2003-10-21 SI SI200331757T patent/SI1558595T1/sl unknown
- 2003-10-21 AU AU2003301552A patent/AU2003301552B2/en not_active Ceased
- 2003-10-21 BR BRPI0315644A patent/BRPI0315644B8/pt not_active IP Right Cessation
- 2003-10-21 PT PT03809596T patent/PT1558595E/pt unknown
- 2003-10-21 PL PL376324A patent/PL215454B1/pl unknown
- 2003-10-22 AR ARP030103848A patent/AR041697A1/es active IP Right Grant
- 2003-10-22 MY MYPI20034029A patent/MY140886A/en unknown
- 2003-10-23 TW TW092129372A patent/TWI352594B/zh not_active IP Right Cessation
-
2005
- 2005-04-19 HR HRP20050352AA patent/HRP20050352B1/hr not_active IP Right Cessation
- 2005-04-20 EG EGNA2005000151 patent/EG25097A/xx active
- 2005-04-21 IL IL168207A patent/IL168207A/en active IP Right Grant
- 2005-04-22 CR CR7807A patent/CR7807A/es not_active Application Discontinuation
- 2005-05-10 NO NO20052278A patent/NO330741B1/no not_active IP Right Cessation
- 2005-05-19 ZA ZA200504067A patent/ZA200504067B/en unknown
-
2006
- 2006-06-13 HK HK06106749.5A patent/HK1086827A1/xx not_active IP Right Cessation
-
2007
- 2007-10-30 US US11/928,006 patent/US20080056991A1/en not_active Abandoned
-
2010
- 2010-01-15 CY CY20101100040T patent/CY1109924T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG25097A (en) | Piprazinyl and diazapanyl benzamides and benzthioamides. | |
EP1539941A4 (en) | ADZYMES AND THEIR USES | |
ZA200603882B (en) | Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides | |
IL175491A0 (en) | Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides | |
MXPA03001050A (es) | Dispositivo desacelerador de rotacion y utilizacion del mismo. | |
GB0206048D0 (en) | Use | |
AU2003300017A8 (en) | Microprocessor and microprocessor operation | |
GB0227666D0 (en) | Use | |
EP1575534A4 (en) | D4.5 GLYCURONIDASE AND ITS USES | |
HK1088837A1 (en) | Clk-peptide and slk-peptide | |
SI1551805T1 (sl) | Substituirani gama-fenil-delta-laktami in njihova uporaba | |
AU2003296369A8 (en) | Imminoamines and preparation thereof | |
GB0217056D0 (en) | Use | |
ZA200210316B (en) | Composition and its therapeutic use. | |
GB0213878D0 (en) | Use | |
AU2003298129A8 (en) | Floor-furnace chimney and the use thereof | |
IL165112A0 (en) | Variant integrinpolypeptides and thereof | |
AU2003231827A8 (en) | Pseudo-tissues and uses thereof | |
EP1517879A4 (en) | AMINOALKYLPHENOLS AND METHODS OF USE AND MANUFACTURE | |
GB0206838D0 (en) | Use | |
AU2003302173A8 (en) | Spirotetrathiocarbamates and spirooxothiocarbamates | |
EP1660088A4 (en) | PYRIDOMORPHINANES, PYRIDAZINOMORPHINANES AND USE THEREOF | |
EP1487547A4 (en) | MEDIUM FOR PHYSICAL INTERACTION AND ITS RELATED USES | |
GB0230343D0 (en) | Use | |
AU2003216442A8 (en) | Enkurin and uses thereof |